User menu

A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy

Bibliographic reference Villanueva, C. ; Awada, A. ; Campone, M. ; Machiels, Jean-Pascal ; Besse, T. ; et. al. A dose escalating study of cabazitaxel (XRP6258) in combination with capecitabine, in patients (pts) with metastatic breast cancer (MBC) progressing after anthracycline and taxane therapy.15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin(Germany), du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 2, p. 268 (2009)
Permanent URL http://hdl.handle.net/2078.1/58666